Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.81B | 55.48B | 51.06B | 81.53B | 61.79B | 39.74B |
Gross Profit | 13.51B | 6.92B | 3.87B | 31.32B | 19.81B | 4.04B |
EBITDA | 13.88B | 13.39B | 11.37B | 36.96B | 24.48B | 8.68B |
Net Income | 6.88B | 6.11B | 3.82B | 29.20B | 17.94B | 2.85B |
Balance Sheet | ||||||
Total Assets | 87.86B | 87.70B | 82.58B | 93.68B | 72.27B | 56.12B |
Cash, Cash Equivalents and Short-Term Investments | 6.95B | 24.04B | 6.70B | 11.00B | 11.84B | 5.87B |
Total Debt | 17.69B | 16.48B | 14.81B | 15.64B | 15.34B | 15.37B |
Total Liabilities | 30.79B | 29.75B | 27.49B | 28.65B | 26.68B | 25.26B |
Stockholders Equity | 55.98B | 56.92B | 54.03B | 63.99B | 44.51B | 29.85B |
Cash Flow | ||||||
Free Cash Flow | 8.04B | 7.21B | 6.00B | 30.31B | 19.05B | 6.51B |
Operating Cash Flow | 13.31B | 11.41B | 9.64B | 34.48B | 22.02B | 7.83B |
Investing Cash Flow | -7.54B | -7.92B | 4.08B | -21.62B | -8.34B | -1.02B |
Financing Cash Flow | -7.75B | -3.50B | -16.80B | -14.13B | -7.90B | -5.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $1.47B | 5.12 | 14.61% | 3.76% | -7.24% | -16.39% | |
80 Outperform | $1.74B | 3.87 | 13.38% | 3.59% | 5.63% | -17.54% | |
79 Outperform | $1.40B | 4.40 | 9.89% | 0.42% | -0.47% | -22.23% | |
77 Outperform | $32.81B | 4.67 | 12.75% | 10.64% | 16.28% | 567.66% | |
74 Outperform | $3.37B | 6.97 | 19.70% | 1.30% | 8.75% | 56.21% | |
63 Neutral | $10.84B | 15.52 | 7.40% | 2.00% | 2.86% | -14.57% | |
60 Neutral | $1.63B | 0.79 | 59.06% | 55.91% | 43.57% | ― |